We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$51B
AUM Growth
+$15.4B
Cap. Flow
+$11.4B
Cap. Flow %
22.45%
Top 10 Hldgs %
32.55%
Holding
2,383
New
382
Increased
1,739
Reduced
215
Closed
45

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$973M
2
MSFT icon
Microsoft
MSFT
+$944M
3
META icon
Meta Platforms (Facebook)
META
+$686M
4
AMZN icon
Amazon
AMZN
+$561M
5
NVDA icon
NVIDIA
NVDA
+$341M

Top Sells

Rank Stock Value
1
LEG icon
Leggett & Platt
LEG
+$127M
2
PBCT
People's United Financial Inc
PBCT
+$25.8M
3
ALB icon
Albemarle
ALB
+$25.2M
4
CDW icon
CDW
CDW
+$25.2M
5
FDS icon
Factset
FDS
+$23.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Consumer Discretionary 13.39%
3 Communication Services 11.47%
4 Healthcare 9.06%
5 Consumer Staples 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSTX
2201
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$103K ﹤0.01%
15,084
-1,918
-11% -$13.1K
RMO
2202
DELISTED
Romeo Power, Inc.
RMO
$103K ﹤0.01%
28,255
+12,113
+75% +$52.3K
CTMX icon
2203
CytomX Therapeutics
CTMX
$705M
$102K ﹤0.01%
23,322
+1,090
+5% +$6.38K
HBIO icon
2204
Harvard Bioscience
HBIO
$27.1M
$101K ﹤0.01%
+1,433
New +$102K
STTK icon
2205
Shattuck Labs
STTK
$710M
$101K ﹤0.01%
+11,758
New +$162K
PASG icon
2206
Passage Bio
PASG
$15.9M
$100K ﹤0.01%
786
-29
-4% -$4.74K
ZVRA icon
2207
Zevra Therapeutics
ZVRA
$563M
$100K ﹤0.01%
+11,452
New +$102K
EOLS icon
2208
Evolus
EOLS
$394M
$98K ﹤0.01%
+15,079
New +$103K
RBBN icon
2209
Ribbon Communications
RBBN
$354M
$97K ﹤0.01%
+16,026
New +$95K
VBIV
2210
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$97K ﹤0.01%
1,372
+577
+73% +$48.6K
ARAY icon
2211
Accuray
ARAY
$28.4M
$95K ﹤0.01%
19,691
+7,838
+66% +$37.8K
ORGO icon
2212
Organogenesis Holdings
ORGO
$308M
$95K ﹤0.01%
+10,306
New +$109K
EGIO
2213
DELISTED
Edgio, Inc. Common Stock
EGIO
$94K ﹤0.01%
683
+283
+71% +$33.6K
CTT
2214
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$93K ﹤0.01%
+10,687
New +$95.2K
CBAY
2215
DELISTED
Cymabay Therapeutics
CBAY
$92K ﹤0.01%
27,065
+3,443
+15% +$13.1K
EZPW icon
2216
Ezcorp Inc
EZPW
$1.82B
$91K ﹤0.01%
+12,431
New +$94.4K
NAUT icon
2217
Nautilus Biotechnolgy
NAUT
$215M
$91K ﹤0.01%
+17,485
New +$93.6K
EVC icon
2218
Entravision Communication
EVC
$983M
$90K ﹤0.01%
+13,149
New +$99.4K
BLU
2219
DELISTED
BELLUS Health Inc.
BLU
$89K ﹤0.01%
+11,031
New +$73.2K
RYAM icon
2220
Rayonier Advanced Materials
RYAM
$565M
$88K ﹤0.01%
+15,495
New +$101K
EPZM
2221
DELISTED
Epizyme, Inc
EPZM
$87K ﹤0.01%
34,618
+1,270
+4% +$4.99K
EVLO
2222
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$86K ﹤0.01%
+708
New +$120K
AKUS
2223
DELISTED
Akouos Inc
AKUS
$86K ﹤0.01%
10,106
-336
-3% -$3.01K
WTTR icon
2224
Select Water Solutions
WTTR
$2.51B
$84K ﹤0.01%
+13,652
New +$84.9K
TCRT icon
2225
Alaunos Therapeutics
TCRT
$4.74M
$83K ﹤0.01%
508
+22
+5% +$4.83K
87 88
89
90 91

Similar funds

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

ProShare Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ProShare Advisors held 2,383 positions worth $51B, up 43% from $35.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

ProShare Advisors deployed $11.4B of net new capital in Q4 2021, opening 382 new positions and adding to 1,739 existing holdings. Its largest new stake was Lucid Motors: 272,628 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Leggett & Platt, an estimated $127M trimmed.

  • ProShare Advisors's largest Q4 2021 buy was Lucid Motors: 272,628 shares worth $104M.
  • ProShare Advisors added most to Apple in Q4 2021, an estimated $973M increase.
  • ProShare Advisors's biggest Q4 2021 reduction was Leggett & Platt, cutting an estimated $127M.
  • ProShare Advisors fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $20.9M.
  • ProShare Advisors's ten largest holdings make up 33% of its $51B portfolio in Q4 2021.
  • ProShare Advisors opened 382 new positions and closed 45 in Q4 2021.
  • ProShare Advisors's portfolio value rose 43% quarter-over-quarter to $51B.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.